ICH M10 Bioanalytical Method Validation Guideline-1 year Later.

AAPS J

Division of Cardiometabolic and Endocrine Pharmacology (DCEP), Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA), Silver Spring, Maryland, USA.

Published: September 2024

The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) adopted Guideline M10 entitled "Bioanalytical Method Validation and Study Sample Analysis" in May 2022. In October 2023, approximately one year after the adoption of the ICH M10 guideline, a "Hot Topic" session was held during the AAPS PharmSci 360 meeting to discuss the implementation of the guideline. The session focused on items the bioanalytical community felt were challenging to implement or ambiguous within the guideline. These topics included cross-validation, parallelism, comparative bioavailability studies, combination drug stability, endogenous analyte bioanalysis, and dilution QCs. In addition, the regulatory perspective on the guideline was presented. This report provides a summary of the Hot Topic session.

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12248-024-00974-yDOI Listing

Publication Analysis

Top Keywords

ich m10
8
method validation
8
guideline
5
m10 bioanalytical
4
bioanalytical method
4
validation guideline-1
4
guideline-1 year
4
year international
4
international council
4
council harmonization
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!